29 min listen
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
Meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus
ratings:
Length:
19 minutes
Released:
May 13, 2019
Format:
Podcast episode
Description
In the first segment, Dr. Lindsay Higdon talks with Dr. Ivan Sanchez Fernandez about his paper on the meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus. In the second part of the podcast, Dr. Stacey Clardy talks with Dr. Anthony Fauci about the measles outbreak of 2019. You can read the paper in NEJM: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.
Released:
May 13, 2019
Format:
Podcast episode
Titles in the series (100)
December 11 2007 Issue: Clinical, electrophysiological and pathological evidence for sensory abnormalities in ALS by Neurology® Podcast